Navigating treatment transitions: Enhancing outpatient recovery with morphine milligram equivalent (MME) dosing in methadone to buprenorphine transition—Case reports
Journal of Opioid Management · 2025
DOI: 10.5055/jom.0923 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Opioid Management, 2025. Verfasst von Wali Yousufzai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Texas Tech University Health Sciences Center, Lubbock, Texas. ORCID: https://orcid.org/0000-0003-1331-8272. Hauptthemen laut MEDLINE: Methadone, Opiate Substitution Treatment, Opioid-Related Disorders, Buprenorphine, Naloxone Drug Combination. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Objectives
To evaluate the effectiveness of transitioning patients from methadone to buprenorphine/naloxone (BUP/NLX) using morphine milligram equivalent (MME) dosing, with a focus on treatment adherence, withdrawal management, and therapeutic response, as illustrated through two patient case studies.
Methods
Two participants (male, 33 years; female 42 years) were treated between June 2023 to January 2024 for opioid use disorder, undergoing BUP/NLX induction from methadone in an opioid treatment program. MME low-dose initiations were utilized for dosage conversion. Data collected included patient demographics, vital signs, Clinical Opiate Withdrawal Scale assessment, MME low-dose initiation calculations, adverse events, treatment adherence, and outcomes.
Results
MME dosing was based on initial methadone dosage and standard MME conversion ratios. Case 1: Sublingual BUP/NLX was started at 0.5 mg, increased to 0.5 mg twice daily by day 3, and titrated until day 17; methadone (24 mg) was tapered off by day 17. Case 2: A similar initiation and tapering process was followed; methadone (11 mg) was discontinued by day 12. Both cases achieved stabilization on BUP/NLX without severe adverse events or precipitated withdrawal symptoms.
Conclusions
MME low-dose initiations appear to be a feasible and safe method for BUP/NLX induction. Further research involving patients on higher methadone doses and larger sample sizes, along prospective designs, is necessary to validate these findings and explore the long-term effectiveness and safety of MME-guided induction protocols across various clinical settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Texas Tech University Health Sciences Center, Lubbock, Texas. ORCID: https://orcid.org/0000-0003-1331-8272.
- Texas Tech University Health Sciences Center, School of Medicine, Lubbock, Texas.
- Texas Tech University Health Sciences Center, Lubbock, Texas.
- UT Southwestern Medical Center/Parkland Hospital System, Department of Psychiatry, Dallas, Texas.
Zitieren
APA
Yousufzai, W., Credo, R., Baronia, R., Marambage, K., & Alag, P. (2025). Navigating treatment transitions: Enhancing outpatient recovery with morphine milligram equivalent (MME) dosing in methadone to buprenorphine transition—Case reports. Journal of Opioid Management. https://doi.org/10.5055/jom.0923
Vancouver
Yousufzai W, Credo R, Baronia R, Marambage K, Alag P. Navigating treatment transitions: Enhancing outpatient recovery with morphine milligram equivalent (MME) dosing in methadone to buprenorphine transition—Case reports. Journal of Opioid Management. 2025. doi:10.5055/jom.0923
BibTeX
@article{Yousufzai2025,
author = {Yousufzai, Wali and Credo, Roald and Baronia, Regina and Marambage, Kapila and Alag, Poorvanshi},
title = {Navigating treatment transitions: Enhancing outpatient recovery with morphine milligram equivalent (MME) dosing in methadone to buprenorphine transition—Case reports},
journal = {Journal of Opioid Management},
year = {2025},
doi = {10.5055/jom.0923}
}
EUVIMED